Activity of human immunodeficiency virus type 1 promoter TAR regions and tat1 genes derived from individuals with different rates of disease progression

被引:29
作者
Kirchhoff, F
Greenough, TC
Hamacher, M
Sullivan, JL
Desrosiers, RC
机构
[1] UNIV MASSACHUSETTS, SCH MED, WORCESTER, MA 01605 USA
[2] HARVARD UNIV, SCH MED, NEW ENGLAND REG PRIMATE RES CTR, SOUTHBOROUGH, MA 01772 USA
关键词
D O I
10.1006/viro.1997.8586
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Different rates of disease progression may be associated with different human immunodeficiency virus type 1 (HIV-I) promoter and/or transactivator activities. We therefore analyzed the sequences and activities of the first exon of Tat, tat1, and the prometer/trans-acting responsive (TAR) regions amplified directly from peripheral blood mononuclear cells obtained from five long-term nonprogressors and eight progressing HIV-1-infected individuals. The majority of tat1 alleles and promoter/TAR regions from all patients were intact and showed comparable activities in transient reporter assays, A substantial number of point mutations and some length variations were observed in the promoter/TAR region. In a single nonprogressor, the Spl binding site 3 was consistently altered and the transcriptional activity in the presence of Tat was diminished. Some LTR clones from a rapid progressor contained a fourth Spl binding site, which was associated with an elevated basal promoter activity. These data suggest that defects in the promoter/TAR region or tat1 are rare and that different promoter/transactivator activities are not commonly associated with different progression rates. (C) 1997 Academic Press.
引用
收藏
页码:319 / 331
页数:13
相关论文
共 38 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[3]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[4]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408
[6]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[7]   GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS [J].
DEACON, NJ ;
TSYKIN, A ;
SOLOMON, A ;
SMITH, K ;
LUDFORDMENTING, M ;
HOOKER, DJ ;
MCPHEE, DA ;
GREENWAY, AL ;
ELLETT, A ;
CHATFIELD, C ;
LAWSON, VA ;
CROWE, S ;
MAERZ, A ;
SONZA, S ;
LEARMONT, J ;
SULLIVAN, JS ;
CUNNINGHAM, A ;
DWYER, D ;
DOWTON, D ;
MILLS, J .
SCIENCE, 1995, 270 (5238) :988-991
[8]   EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF AND LONG TERMINAL REPEAT SEQUENCES OVER 4 YEARS INVIVO AND INVITRO [J].
DELASSUS, S ;
CHEYNIER, R ;
WAINHOBSON, S .
JOURNAL OF VIROLOGY, 1991, 65 (01) :225-231
[9]   HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN BINDS TRANS-ACTIVATION-RESPONSIVE REGION (TAR) RNA INVITRO [J].
DINGWALL, C ;
ERNBERG, I ;
GAIT, MJ ;
GREEN, SM ;
HEAPHY, S ;
KARN, J ;
LOWE, AD ;
SINGH, M ;
SKINNER, MA ;
VALERIO, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :6925-6929
[10]   Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity [J].
Estable, MC ;
Bell, B ;
Merzouki, A ;
Montaner, JSG ;
OShaughnessy, MV ;
Sadowski, IJ .
JOURNAL OF VIROLOGY, 1996, 70 (06) :4053-4062